TriSalus Life Sciences Inc (TLSI)
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
Capricor Therapeutics Announces Proposed Public Offering of Common Stock
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Praxis Precision Medicines Announces Positive Pre-NDA Meeting with FDA for Ulixacaltamide in Essential Tremor
UTHR: Notification
Codexis Featured in CBS’s Economy 4.0 Docuseries Highlighting RNA Manufacturing Innovation
New SEC Form for ResMed Inc.
Halozyme - Halozyme Wins Preliminary Injunction Against Mercks Keytruda SC in Germany
Halozyme Wins Preliminary Injunction Against Mercks Keytruda SC in Germany